Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research

J Brandt, C Leong - Drugs in R&D, 2017 - Springer
Various adverse events resulting from, or associated with, benzodiazepine and/or Z-drug
use have been extensively reported on and discussed in great detail within the biomedical …

Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies

R Elvik - Accident Analysis & Prevention, 2013 - Elsevier
This paper is a corrigendum to a previously published paper where errors were detected.
The errors have been corrected in this paper. The paper is otherwise identical to the …

Medication use and the risk of motor vehicle collisions among licensed drivers: a systematic review

TM Rudisill, M Zhu, GA Kelley, C Pilkerton… - Accident Analysis & …, 2016 - Elsevier
Objectives Driving under the influence of prescription and over-the-counter medication is a
growing public health concern. A systematic review of the literature was performed to …

[HTML][HTML] Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit

DF Kripke - F1000Research, 2016 - ncbi.nlm.nih.gov
This is a review of hypnotic drug risks and benefits. Almost every month, new information
appears about the risks of hypnotics (sleeping pills). The most important risks of hypnotics …

Age-related diseases and driving safety

M Falkenstein, M Karthaus, U Brüne-Cohrs - Geriatrics, 2020 - mdpi.com
Due to demographic changes, the number of older drivers is steadily increasing. Mobility is
highly relevant for leading an independent life in the elderly. It largely depends on car …

[PDF][PDF] Driving under the influence of non-alcohol drugs–an update. Part I: epidemiological studies

H Gjerde, MC Strand, J Mørland - 2015 - fhi.brage.unit.no
Epidemiological studies of the association between drug use and involvement in road traffic
crashes (RTCs) published from January 1998 to February 2015 have been reviewed. Cohort …

Zolpidem for insomnia

DJ Greenblatt, T Roth - Expert opinion on pharmacotherapy, 2012 - Taylor & Francis
Introduction: The imidazopyridine derivative zolpidem, which acts as a benzodiazepine (BZ)
receptor agonist, is the most widely prescribed hypnotic drug in the US. Areas covered: This …

Non-GABA sleep medications, suvorexant as risk factors for falls: case-control and case-crossover study

Y Ishibashi, R Nishitani, A Shimura, A Takeuchi… - PLoS …, 2020 - journals.plos.org
The aim of this study was to examine the risk of falls associated with the use of non-gamma
amino butyric acid (GABA) sleep medications, suvorexant and ramelteon. This case-control …

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European …

E Clay, B Falissard, N Moore, M Toumi - European journal of clinical …, 2013 - Springer
Background Benzodiazepines (BZD) and benzodiazepine receptor agonists (zolpidem,
zaleplon, zopiclone, altogether Z-drugs) are most commonly prescribed for the treatment of …

Drugs for insomnia

N Zisapel - Expert opinion on emerging drugs, 2012 - Taylor & Francis
Introduction: Sleep is a vital neurochemical process involving sleep-promoting and arousal
centers in the brain. Insomnia is a pervasive disorder characterized by difficulties in initiating …